NL-OMON27157已完成不适用
High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemia.
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl0 个研究点目标入组 102 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
Ann Hematol. 2007 Feb;86(2):117-25. Epub 2006 Oct 10.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Newly diagnosed patients with CML in first chronic phase <= 6 months;
- •2. Presence of Philadelphia chromosome or BCR/ABL rearrangement;
排除标准
- •1. CML in blastic phase;
- •2. CML in accelerated phase;
研究者
相似试验
已完成
不适用
High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemiaChronic myeloid leukemia (CML)Myeloid leukaemiaCancerISRCTN84226319Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)102
招募中
不适用
Modified Low dose Cytarabine versus Hypomethylating agent in Elderly AML patients who are unfit for intensive chemotherapy: Randomized clinical studyDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0001891The Catholic University of Korea, Seoul St. Mary's Hospital50
尚未招募
3 期
Comparison of a condensed schedule of high dose cytarabine consolidation to the conventional schedule of high dose cytarabine consolidation in the treatment of acute myeloid leukemiaCTRI/2020/05/025475Medical College Hospital Kolkata
已完成
4 期
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AMLCore-Binding FactorAcute Myeloid LeukemiaNCT02926586Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine68
已完成
2 期
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic LeukemiaLeukemiaNCT01656031Wake Forest University Health Sciences39